Found: 25
Select item for more details and to access through your institution.
Two years of COVID-19 in the MS community: What have we learnt so far?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Validation of a Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS) and comparison with reference batteries.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1112, doi. 10.1177/13524585211054006
- By:
- Publication type:
- Article
Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1041, doi. 10.1177/13524585221094478
- By:
- Publication type:
- Article
MOG antibody–associated longitudinal extensive myelitis after Oxford-Astra Zeneca's COVID-19 vaccination.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1163, doi. 10.1177/13524585211066771
- By:
- Publication type:
- Article
Low-dose rituximab should be used for treating MS in resource-limited settings: Yes.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1028, doi. 10.1177/13524585221089890
- By:
- Publication type:
- Article
Low-dose rituximab should be used for treating MS in resource-limited settings: Commentary.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1032, doi. 10.1177/13524585221098612
- By:
- Publication type:
- Article
Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1138, doi. 10.1177/13524585221089540
- By:
- Publication type:
- Article
Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1146, doi. 10.1177/13524585221092309
- By:
- Publication type:
- Article
Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1131, doi. 10.1177/13524585211061343
- By:
- Publication type:
- Article
MOG-antibody-associated longitudinal extensive myelitis after ChAdOx1 nCoV-19 vaccination.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1159, doi. 10.1177/13524585211057512
- By:
- Publication type:
- Article
Low-dose rituximab should be used for treating MS in resource-limited settings: No.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1030, doi. 10.1177/13524585221089889
- By:
- Publication type:
- Article
Effects of voice rehabilitation in people with MS: A double-blinded long-term randomized controlled trial.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1081, doi. 10.1177/13524585211051059
- By:
- Publication type:
- Article
Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis optica.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1155, doi. 10.1177/13524585211049737
- By:
- Publication type:
- Article
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1034, doi. 10.1177/13524585211035318
- By:
- Publication type:
- Article
Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: Baseline analyses from the CogEx study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1091, doi. 10.1177/13524585211048397
- By:
- Publication type:
- Article
Demyelinating disorders following COVID-19 vaccination.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1154, doi. 10.1177/13524585211046903
- By:
- Publication type:
- Article
Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registry.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1051, doi. 10.1177/13524585211026272
- By:
- Publication type:
- Article
Interpreting change on the Symbol Digit Modalities Test in people with relapsing multiple sclerosis using the reliable change methodology.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1101, doi. 10.1177/13524585211049397
- By:
- Publication type:
- Article
ADEM after ChAdOx1 nCoV-19 vaccine: A case report.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1151, doi. 10.1177/13524585211040222
- By:
- Publication type:
- Article
COVID-19 vaccine hesitancy in multiple sclerosis: A cross-sectional survey.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1072, doi. 10.1177/13524585211030647
- By:
- Publication type:
- Article
Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1121, doi. 10.1177/13524585211028833
- By:
- Publication type:
- Article
Diminished seroconversion following a single SARS-COV-2 vaccine in ocrelizumab-treated relapsing-remitting multiple sclerosis patients.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1126, doi. 10.1177/13524585211046786
- By:
- Publication type:
- Article
Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case–control study of the UK MS Register.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1060, doi. 10.1177/13524585211020435
- By:
- Publication type:
- Article
Fatigue, depression, and pain in multiple sclerosis: How neuroinflammation translates into dysfunctional reward processing and anhedonic symptoms.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1020, doi. 10.1177/1352458520972279
- By:
- Publication type:
- Article
Focus on neglected features of cognitive rehabilitation in MS: Setting and mode of the treatment.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1009, doi. 10.1177/1352458520966300
- By:
- Publication type:
- Article